DrugPatentWatch Database Preview

Drugs in Development Information for Papaverine

« Back to Dashboard

Summary for Papaverine

US Patents	2,724
International Patents	21,706
US Patent Applications	3,964
WIPO Patent Applications	2,518
Japanese Patent Applications	14
Clinical Trial Progress	Phase 3 (2017-05-15)
Vendors	35

US Patents for Papaverine

Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
Papaverine		Methods and compositions for treating infection	UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS)
Papaverine		Implantable human liver tissue constructs and uses thereof	Massachusetts Institute of Technology (Cambridge, MA)
Papaverine		Cytochrome P450 fusion protein	The University of York (York, GB) Sun Pharmaceutical Industries (Australia) Pty Ltd (Notting Hill, Victoria, AU)
Papaverine		Use of diazepinones for treating disorders of the microcirculation	Dr. Karl Thomae GmbH (Biberach an der Riss, DE)
Papaverine		N-aminobutyl-n-phenylarylamide compounds and their application in therapy	Synthelabo (Paris, FR)
Papaverine		2-substituted alkoxy-3-substituted-pyrazines	Toyo Jozo Kabushiki Kaisha (Shizuoka, JP)
Papaverine		KS-501 derivatives	Kyowa Hakko Kogyo Co., Ltd. (Tokyo, JP)

International Patents for Papaverine

Drugname	Country	Document Number	Estimated Expiration	Related US Patent
Papaverine	World Intellectual Property Organization (WIPO)	2014052836	2032-09-27
Papaverine	World Intellectual Property Organization (WIPO)	2012048170	2030-10-06
Papaverine	Australia	2015261278	2034-05-16
Papaverine	Canada	2946812	2034-05-16
Papaverine	European Patent Office	3143125	2034-05-16
Papaverine	United Kingdom	201408729	2034-05-16
Papaverine	United Kingdom	201506805	2034-05-16